IL155100A0 - Pharmaceutical compositions comprising 1-isopropyl-3-[(4-m-toluidino-3-pyridyl) sulphonyl]-urea as active ingredient - Google Patents
Pharmaceutical compositions comprising 1-isopropyl-3-[(4-m-toluidino-3-pyridyl) sulphonyl]-urea as active ingredientInfo
- Publication number
- IL155100A0 IL155100A0 IL15510003A IL15510003A IL155100A0 IL 155100 A0 IL155100 A0 IL 155100A0 IL 15510003 A IL15510003 A IL 15510003A IL 15510003 A IL15510003 A IL 15510003A IL 155100 A0 IL155100 A0 IL 155100A0
- Authority
- IL
- Israel
- Prior art keywords
- toluidino
- sulphonyl
- pyridyl
- urea
- isopropyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002MI000639A ITMI20020639A1 (it) | 2002-03-27 | 2002-03-27 | Composizioni farmaceutiche comprendenti come principio attivo 1-isopropil-3°(4-m-toluidino-3-pridil)sulfonil!-urea |
Publications (1)
Publication Number | Publication Date |
---|---|
IL155100A0 true IL155100A0 (en) | 2003-10-31 |
Family
ID=11449588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15510003A IL155100A0 (en) | 2002-03-27 | 2003-03-26 | Pharmaceutical compositions comprising 1-isopropyl-3-[(4-m-toluidino-3-pyridyl) sulphonyl]-urea as active ingredient |
Country Status (5)
Country | Link |
---|---|
US (2) | US7034159B2 (xx) |
EP (1) | EP1348435A1 (xx) |
CA (1) | CA2423550A1 (xx) |
IL (1) | IL155100A0 (xx) |
IT (1) | ITMI20020639A1 (xx) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104370805B (zh) * | 2013-08-13 | 2016-09-07 | 天津汉瑞药业有限公司 | 托拉塞米化合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3529529A1 (de) * | 1985-08-17 | 1987-02-19 | Boehringer Mannheim Gmbh | Verfahren zur herstellung einer stabilen modifikation von torasemid |
US5914336A (en) * | 1998-06-02 | 1999-06-22 | Boehringer Mannheim Gmbh | Method of controlling the serum solubility of orally administered torasemide and composition relating thereto |
AU781461C (en) * | 1999-08-11 | 2006-02-23 | Teva Pharmaceutical Industries Ltd. | Torsemide polymorphs |
CA2410802A1 (en) * | 2000-02-17 | 2002-09-06 | Minutza Leibovici | A stable pharmaceutical formulation comprising torsemide modification ii |
-
2002
- 2002-03-27 IT IT2002MI000639A patent/ITMI20020639A1/it unknown
-
2003
- 2003-03-26 EP EP03006914A patent/EP1348435A1/en not_active Withdrawn
- 2003-03-26 IL IL15510003A patent/IL155100A0/xx unknown
- 2003-03-26 CA CA002423550A patent/CA2423550A1/en not_active Abandoned
- 2003-03-27 US US10/400,890 patent/US7034159B2/en not_active Expired - Fee Related
-
2006
- 2006-03-01 US US11/366,485 patent/US20070054944A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2423550A1 (en) | 2003-09-27 |
US7034159B2 (en) | 2006-04-25 |
EP1348435A1 (en) | 2003-10-01 |
ITMI20020639A1 (it) | 2003-09-29 |
ITMI20020639A0 (it) | 2002-03-27 |
US20070054944A1 (en) | 2007-03-08 |
US20030187032A1 (en) | 2003-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0501186A2 (en) | Pharmaceutical compositions comprising active vitamin d compounds | |
NO20043702L (no) | 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel | |
DK1498411T3 (da) | Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel | |
IL157741A0 (en) | Pharmaceutical compositions containing an antihyperplastic active agent | |
AU2003213719A8 (en) | Multiple-component solid phases containing at least one active pharmaceutical ingredient | |
EP1631239A4 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE COMPOUNDS OF VITAMIN D | |
IL164798A0 (en) | Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them | |
GB0210397D0 (en) | Pharmaceutical formulations | |
DK1557415T3 (da) | Heterocykliske forbindelser og antitumorlægemidler indeholdende samme som den aktive ingrediens | |
HK1087399A1 (en) | Pharmaceutical formulations comprising highly purebases of 3, 3-giphenylpropylamine monoesters | |
HK1067626A1 (en) | Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient | |
IL162765A (en) | Diazabicycle derivatives, processes for their preparation, pharmaceutical compositions comprising them and their medical use | |
HUP0303948A2 (hu) | Szájban diszpergálódó szilárd gyógyszerforma | |
AU2002364468A1 (en) | Solid orally-dispersible pharmaceutical formulation | |
GB2392093B (en) | Pharmaceutical formulations | |
NO20040860L (no) | Farmasoytisk sammensetning som innbefatter lumiracoxib | |
AU2002340573A8 (en) | Powdery active ingredient formulations | |
HUP0203226A3 (en) | Pharmaceutical composition comprising benzamide derivative as active ingredient | |
HUP0600084A2 (en) | Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient | |
PL374761A1 (en) | N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them | |
IL155100A0 (en) | Pharmaceutical compositions comprising 1-isopropyl-3-[(4-m-toluidino-3-pyridyl) sulphonyl]-urea as active ingredient | |
IL172304A0 (en) | Pharmaceutical compositions comprising active vitamin d compounds | |
EP1480649A4 (en) | STABLE PHARMACEUTICAL COMPOSITIONS | |
HRP20040757A2 (en) | A stable pharmaceutical formulation comprising torsemide modification ii | |
AU2003238900A8 (en) | Pharmaceutical formulation |